Would you consider restarting a SGLT2i at a reduced dose in a patient who you previously discontinued the medication because of an associated significant decline in eGFR?

Would you consider restarting an SGLT2 inhibitor in a patient for whom you previously discontinued the medication due to a significant decline in eGFR?

• Yes, I would restart at a lower dose if the drop in eGFR was thought to be related to volume depletion
• Yes, I would restart at the same dose and emphasize fluid intake if the drop in eGFR was thought to be related to volume depletion
• No, I would not restart an SGLT2i in this situation
• Other